Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06354439

Use of Letrozole for Ectopic Pregnancy (EcZOL)

Use of Letrozole in the Treatment of Early Ectopic Pregnancy

Sponsor: Hospital de Clinicas de Porto Alegre

Interventions Letrozole tablets Methotrexate Sodium

Updated 3 times since 2024 Last updated: Apr 5, 2024 Started: Mar 27, 2024 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Ectopic Pregnancy, this trial is actively recruiting participants. The trial is conducted by Hospital de Clinicas de Porto Alegre and has accumulated 3 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
May 2024 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Clinicas de Porto Alegre

Data source: Hospital de Clinicas de Porto Alegre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto Alegre, Brazil